English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53733666    線上人數 :  1290
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu c j"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 186-195 / 2308 (共231頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-17T02:50:55Z Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis Huang C.-T.; MENG-RUI LEE; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T02:50:52Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T02:50:51Z Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study MENG-RUI LEE; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-15T01:20:52Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2021-09-15T01:20:50Z Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis Chung K.-P.; CHIA-LANG HSU; Fan L.-C.; Huang Z.; Bhatia D.; Chen Y.-J.; Hisata S.; Cho S.J.; Nakahira K.; Imamura M.; Choi M.E.; Yu C.-J.; Cloonan S.M.; Choi A.M.K.
臺大學術典藏 2021-09-15T01:20:46Z Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; CHIA-LANG HSU; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.
臺大學術典藏 2021-09-14T02:45:49Z Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003 Tseng W.-P.; JHONG-LIN WU; Wu C.-C.; Kuo K.-T.; Lin C.-H.; Chung M.-Y.; Lee Y.-F.; Yang B.-J.; Huang C.-H.; Chen S.-Y.; Yu C.-J.; Chen S.-C.; Hsueh P.-R.
臺大學術典藏 2021-09-09T05:25:29Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2021-09-09T05:25:27Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-09-04T06:12:08Z Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; JIA-HORNG KAO; Yang P.-C.

顯示項目 186-195 / 2308 (共231頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目